V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260009387 | 260006080 | 1.59 | null | Curative (C) | 2016-08-24 | 2016-09-06 | Rituximab | N | N | 260029758 | RITUXIMAB |
| 260009388 | 260006081 | 1.96 | 56.3 | Palliative (P) | 2017-12-19 | 2018-01-29 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | 2 | N | 260029759 | CISPLATIN + ETOPOSIDE |
| 260009389 | 260012243 | 1.91 | 71.7 | Curative (C) | 2016-09-14 | 2016-09-14 | Chlorambucil | 02 | N | 260029760 | RITUXIMAB |
| 260009390 | 260012243 | 1.87 | 90 | Curative (C) | null | 2013-03-21 | VIP | N | N | 260029760 | CISPLATIN + ETOPOSIDE |
| 260009391 | 260012243 | 1.87 | 94.7 | Palliative (P) | 2018-03-24 | 2018-04-13 | ABVD | N | N | 260029760 | CISPLATIN + ETOPOSIDE |
| 260009392 | 260006082 | 1.67 | 88.1 | Curative (C) | 2015-05-08 | 2015-05-11 | Rituximab | N | N | 260029766 | ETOPOSIDE |
| 260009393 | 260006082 | 1.65 | null | Palliative (P) | 2018-07-16 | 2018-07-30 | CISPLATIN + RT | N | N | 260029766 | BENDAMUSTINE |
| 260009394 | 260015645 | 1.75 | 76 | Adjuvant (A) | 2017-03-26 | 2017-03-30 | Carboplatin + Etoposide IV 3 day | N | N | 260029769 | CISPLATIN + ETOPOSIDE |
| 260009395 | 260006083 | null | 131 | Palliative (P) | 2015-04-24 | 2015-04-26 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 02 | N | 260029773 | TRIAL |
| 260009396 | 260006083 | 1.85 | 88.5 | Palliative (P) | 2015-02-21 | 2015-02-26 | Cisplatin + Etoposide (5 day) | N | N | 260029773 | VIP |
| 260009397 | 260006083 | 1.8 | null | Adjuvant (A) | 2015-03-15 | 2015-03-15 | GEMCARBO | 02 | N | 260029773 | NOT MATCHED |
| 260009398 | 260006083 | 1.79 | null | Disease modification (D) | 2014-10-10 | 2014-10-22 | Cisplatin + Etoposide (5 day) | N | N | 260029773 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260009399 | 260006084 | 1.8 | 0 | Palliative (P) | 2016-04-27 | 2016-04-29 | Cisplatin + Etoposide (5 day) | N | N | 260029783 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260009400 | 260006084 | 1.8 | 67 | Curative (C) | 2015-05-09 | 2016-04-10 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 02 | N | 260029783 | RITUXIMAB |
| 260009401 | 260006085 | null | 59.3 | Not known (9) | 2013-12-15 | 2013-12-29 | Carboplatin + Vinorelbine Oral | N | N | 260029788 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 260009402 | 260006085 | 1.7 | null | Curative (C) | 2014-08-16 | 2014-08-23 | Cisplatin + Etoposide (3 day) | 02 | N | 260029788 | TIP |
| 260009403 | 260006085 | 1.69 | 63 | null | null | 2013-03-06 | Cisplatin + Etoposide (5 day) | 02 | N | 260029788 | CISPLATIN + ETOPOSIDE |
| 260009404 | 260006085 | 1.58 | 90 | null | 2017-10-07 | 2017-10-13 | R Chlorambucil | N | N | 260029788 | CARBOPLATIN + PACLITAXEL |
| 260009405 | 260006085 | 1.73 | 82 | Curative (C) | 2015-11-10 | 2015-11-23 | Carboplatin + Etoposide IV 3 day | N | N | 260029788 | NOT MATCHED |
| 260009406 | 260006086 | null | 97.1 | null | 2016-11-10 | 2016-11-11 | CARBOPLATIN + ETOPOSIDE | 99 | N | 260029797 | TIP |
| 260009407 | 260006087 | null | 57.2 | null | 2013-11-10 | 2013-11-28 | Cisplatin + Vinorelbine (IV) | N | N | 260029799 | CISPLATIN + ETOPOSIDE |
| 260009408 | 260006087 | 1.74 | null | Curative (C) | 2014-01-17 | 2014-01-22 | Cisplatin + Etoposide (5 day) | 02 | N | 260029799 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260009409 | 260006088 | 1.84 | 78.8 | Curative (C) | 2015-01-23 | 2015-02-05 | CISPLATIN + ETOPOSIDE | 01 | null | 260029803 | CARBOPLATIN + ETOPOSIDE |
| 260009410 | 260006088 | 1.55 | null | Curative (C) | 2017-11-10 | 2017-11-10 | Rituximab | 02 | N | 260029803 | RITUXIMAB |
| 260009411 | 260006089 | 1.6 | 77 | Palliative (P) | 2013-04-01 | 2013-04-16 | Bendamustine +/- Prednisolone | Y | N | 260029807 | RITUXIMAB |
| 260009412 | 260006089 | 1.95 | null | Curative (C) | null | 2014-08-03 | EP | N | N | 260029807 | ETOPOSIDE |
| 260009413 | 260006089 | 1.55 | null | Curative (C) | 2016-06-26 | 2016-06-26 | FCR Oral - Cycle 1 | N | N | 260029807 | RITUXIMAB |
| 260009414 | 260006089 | 1.69 | 66 | Palliative (P) | 2016-12-06 | 2016-12-09 | CHOP - 21 days | 02 | N | 260029807 | RITUXIMAB |
| 260009415 | 260006089 | 1.69 | 84 | null | 2016-02-02 | 2016-02-04 | CISPLATIN + ETOPOSIDE | N | null | 260029807 | CISPLATIN + ETOPOSIDE |
| 260009416 | 260006089 | null | 82.7 | Curative (C) | 2014-12-29 | 2015-01-05 | Rituximab | 02 | N | 260029807 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE |
| 260009417 | 260006090 | 1.57 | 94.3 | Adjuvant (A) | null | 2016-08-31 | Carboplatin + Pemetrexed | null | null | 260029821 | BLEOMYCIN + VINCRISTINE |
| 260009418 | 260006091 | 1.56 | 60 | Disease modification (D) | 2015-01-23 | 2015-01-26 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 260029822 | CARBOPLATIN + PACLITAXEL |
| 260009419 | 260012251 | null | null | Curative (C) | 2018-04-01 | 2018-04-02 | EP 1 2 or 3 day | 99 | null | 260029823 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260009420 | 260012251 | 1.7 | null | null | 2017-07-09 | 2017-07-11 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 02 | N | 260029823 | CISPLATIN + ETOPOSIDE |
| 260009421 | 260006092 | 1.77 | 79.4 | null | 2017-12-05 | 2018-01-08 | EP | 1 | null | 260029829 | RITUXIMAB |
| 260009422 | 260006092 | 1.91 | 63 | Curative (C) | null | 2013-11-18 | ETOPOSIDE | 02 | N | 260029829 | CISPLATIN + ETOPOSIDE |
| 260009423 | 260006093 | 1.81 | 103.3 | Adjuvant (A) | 2018-01-02 | 2018-01-04 | Cisplatin + Etoposide (3 day) | N | N | 260029833 | EP |
| 260009424 | 260006094 | 1.62 | 62.5 | Not known (9) | 2015-03-28 | 2015-03-28 | Rituximab (Maintenance) | 02 | N | 260029834 | RITUXIMAB |
| 260009425 | 260006094 | 1.8 | 73.2 | Disease modification (D) | 2013-08-12 | 2013-08-12 | CARBOPLATIN + VINORELBINE | 02 | N | 260029834 | CISPLATIN + ETOPOSIDE |
| 260009426 | 260006095 | null | null | null | 2017-11-18 | 2017-12-09 | Cisplatin + Etoposide (3 day) | N | N | 260029841 | CISPLATIN + ETOPOSIDE |
| 260009427 | 260006096 | 1.82 | 87.5 | Palliative (P) | 2015-03-13 | 2015-03-13 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + FILGRASTIM + METHOTREXATE | N | N | 260029842 | GEMCARBO |
| 260009428 | 260012254 | 1.75 | 101.3 | Disease modification (D) | 2016-10-30 | 2016-11-01 | Cisplatin + Etoposide (3 day) | null | N | 260029845 | TRIAL |
| 260009429 | 260006097 | null | null | null | null | 2014-03-12 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | null | null | 260029846 | ACE (GERM CELL) |
| 260009430 | 260006097 | 1.74 | null | Curative (C) | 2018-05-23 | 2018-06-15 | TIP | N | N | 260029846 | CISPLATIN + ETOPOSIDE |
| 260009431 | 260006098 | 1.68 | 91.6 | Palliative (P) | 2017-08-16 | 2017-08-21 | ETOPOSIDE + RITUXIMAB | N | N | 260029848 | CISPLATIN + ETOPOSIDE |
| 260009432 | 260006099 | 1.73 | 95.6 | Adjuvant (A) | 2014-12-19 | 2015-01-09 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + FILGRASTIM + METHOTREXATE | N | N | 260029849 | CARBOPLATIN + PEMETREXED |
| 260009433 | 260006099 | 1.69 | 72.4 | Curative (C) | 2015-06-23 | 2015-07-05 | CARBOPLATIN + ETOPOSIDE | N | N | 260029849 | GEMCARBO |
| 260009434 | 260006099 | 1.75 | 73 | null | 2014-11-12 | 2014-12-15 | Rituximab | N | N | 260029849 | CHOP |
| 260009435 | 260006099 | 1.63 | 48 | null | 2016-06-05 | 2016-06-08 | Rituximab | 02 | N | 260029849 | RITUXIMAB |
| 260009436 | 260006099 | 1.74 | 56.3 | null | 2013-05-24 | 2013-07-17 | Cisplatin + Etoposide (5 day) | 02 | null | 260029849 | CISPLATIN + ETOPOSIDE |